16 мая 2021 г. · The HOST-EXAM trial was an investigator-initiated, prospective, randomised, open-label, multicentre trial done at 37 study sites in South Korea.

17 апр. 2023 г. · The HOST-EXAM trial showed that clopidogrel monotherapy is superior to aspirin monotherapy as chronic maintenance therapy among patients.

7 нояб. 2022 г. · The HOST-EXAM Extended study supports clopidogrel as the preferable antiplatelet agent prescribed for secondary prevention of coronary artery disease.

26 июн. 2021 г. · We aimed to compare head to head the efficacy and safety of aspirin and clopidogrel monotherapy in this population. Methods: We did an ...

11 мая 2021 г. · To compare the efficacy and safety between aspirin versus clopidogrel monotherapy as chronic maintenance therapy in patients who received PCI ...

The HOST-EXAM trial reported superiority of Clopidogrel over Aspirin monotherapy during a 2- year follow-up in stable CAD pts who were event-free under DAPT for ...

7 нояб. 2022 г. · Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy After Percutaneous Coronary Intervention: The HOST-EXAM Extended Study.

1 июн. 2023 г. · Aspirin vs Clopidogrel for Long-term Maintenance After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the HOST-EXAM Trial.

12 апр. 2023 г. · This secondary analysis of the HOST-EXAM randomized clinical trial evaluates clopidogrel vs aspirin for long-term maintenance after ...

18 июн. 2021 г. · The HOST-EXAM is the first large-scale randomized trial comparing clopidogrel with aspirin as chronic maintenance antithrombotic monotherapy after 6 to 18 ...